Although no difference has been found in the expression of TGF-β between lichen sclerosus and healthy skin, there are no studies comparing this marker as a function of different therapies, nor of its association with collagen synthesis in VLS [36]. Here, TGFB1 is linked to lichen sclerosus et atrophicus.